The Biomedical Advanced Research and Development
Authority (BARDA) is responsible for the U.S. government's procurement and
advanced development of medical countermeasures for chemical, biological,
radiological and nuclear agents for the civilian population, based on threats
identified in Department of Homeland Security Material Threat
Determinations. BARDA is funding advanced development and/or procurement of
countermeasures for three of the 12 biological agents identified by DHS, as
well as broad spectrum antimicrobials (BSA), which could, in